Salenius, Karoliina
Väljä, Niina
Thusberg, Sini
Iris, Francois
Ladd-Acosta, Christine
Roos, Christophe
Nykter, Matti
Fasano, Alessio
Autio, Reija
Lin, Jake
,
Funding for this research was provided by:
Horizon 2020 Framework Programme (825033)
Horizon 2020 Framework Programme (825033)
Horizon 2020 Framework Programme (825033)
Horizon 2020 Framework Programme (825033)
Horizon 2020 Framework Programme (825033)
Horizon 2020 Framework Programme (825033)
Horizon 2020 Framework Programme (825033)
Horizon 2020 Framework Programme (825033)
Horizon 2020 Framework Programme (825033)
Horizon 2020 Framework Programme (825033)
Horizon 2020 Framework Programme (825033)
Tampere University
Article History
Received: 1 August 2024
Accepted: 8 December 2024
First Online: 18 December 2024
Declarations
:
: The GEMMA study was approved by the relevant ethics committee of each enrolling country. Particularly, CE Campania Sud (IRB n.30/2019) for Italy; Partners Human Research (IRB ver.01/04/2019) for USA; and Clinical Research Ethics Committee of Galway University Hospital (IRB n. C.A. 2127/19) for Ireland. A written consent form will be signed by each participant or their legal representative.
: Consent, relevant to GEMMA subjects, is granted and signed by each participant or their legal representative.
: The authors declare no competing interests.